Form 4 for AVTR Avantor, Inc.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-27 · accession 0001722482-23-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | 2023-02-27 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,059 | 112.6K | -3% | -$76.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 3,059 | $25.00 | 112,629 | D | — | — |